WHO tracking mechanism for IHR additional health measures
In February, 2018, WHO in collaboration with The University of Sydney, NSW, Australia, launched a new tool to monitor compliance with the International Health Regulations (2005) (IHR 2005) requirements regarding additional health measures. The initiative is part of the WHO Secretariat's commitment to strengthening the IHR framework, which is a legally binding instrument to protect global public health and prevent unnecessary disruption to international traffic and trade; this framework has been adopted by 196 States Parties, including all 194 Member States of WHO.
Debate over a new idea for stopping malaria is pitting some environmental groups against Bill Gates.
Current clinical practice guidelines have identified a new category of heart failure: heart failure with improved ejection fraction.1,2 Multiple observational series on heart failure show improved mea
Many patients deemed to have recovered from dilated cardiomyopathy will relapse following treatment withdrawal. Until robust predictors of relapse are defined, treatment should continue indefinitely.
Concerns about the growing burden of diabetes are mounting.1 Temporal analyses suggest that cardiovascular risk in people with diabetes persists and, if anything, is widening for fatal outcomes.2 The
SGLT2i have moderate benefits on atherosclerotic major adverse cardiovascular events that seem confined to patients with established atherosclerotic cardiovascular disease. However, they have robust b
In 1928, London's medical schools were under attack from some angry tax payers. In letters to The Times, women demanded that in return for their contributions to the national economy they should have
The adoption of the Declaration of Astana (panel) at the Global Conference on Primary Health Care (PHC) in Astana, Kazakhstan, on Oct 25-26, 2018, has built considerable momentum around a renewed visi
The non-inferior efficacy and similar tolerability profile of dolutegravir plus lamivudine to a guideline-recommended three-drug regimen at 48 weeks in ART-naive adults supports its use as initial the
Since the early days of antiretroviral therapy (ART), HIV treatments have greatly improved in terms of toxicity profiles, dosing requirements, virological potency, and genetic barriers for emerging dr
The Millennium Development Goal (MDG) era witnessed an unprecedented drop in mortality among children younger than 5 years and in undernutrition across all regions. However, the poorest children remai
Since The Lancet published the first Global Burden of Disease Study (GBD) over 10 years ago, every new iteration has brought improvements in data quality and quantity. With the sharpening of these est
Population trends create demographic dividends and headwinds (ie, economic benefits and detriments) that affect national economies and determine national planning needs. Although TFRs are decreasing,
Improvements in global health have been unevenly distributed among populations. Deaths due to injuries, substance use disorders, armed conflict and terrorism, neoplasms, and cardiovascular disease are
Global all-cause age-standardised YLD rates have improved only slightly over a period spanning nearly three decades. However, the magnitude of the non-fatal disease burden has expanded globally, with
This analysis of age-sex-specific mortality shows that there are remarkably complex patterns in population mortality across countries. The findings of this study highlight global successes, such as th
The GBD study offers a unique, robust platform for monitoring the health-related SDGs across demographic and geographic dimensions. Our findings underscore the importance of increased collection and a
Misdiagnosis by physicians occurs in approximately 5% of outpatients.1 Computerised diagnostic decision support (CDDS) programmes can help, and interest in this area has increased alongside advances i
Arthropod-borne viruses (arboviruses) are some of the most important human pathogens in the world yet developing countermeasures to them is challenging and rarely leads to licensed products. A small n
MV-CHIK showed excellent safety and tolerability and good immunogenicity, independent of pre-existing immunity against the vector. MV-CHIK is a promising candidate vaccine for the prevention of chikun
Major depression is a common illness that severely limits psychosocial functioning and diminishes quality of life. In 2008, WHO ranked major depression as the third cause of burden of disease worldwid